Optimizing light dosimetry in photodynamic therapy of the bronchi by fluorescence spectroscopy

This publication has 12 references indexed in Scilit:

• Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy
  Lasers in Surgery and Medicine, 1996
• Clinical pharmacokinetic studies of tetra(meta‐hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths
  International Journal of Cancer, 1995
• Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi
  Cancer, 1995
• Evaluation of a new photosensitizer, meso‐tetra‐hydroxyphenyl‐chlorin, for use in photodynamic therapy: A comparison of its photobiological properties with those of two other photosensitizers
  International Journal of Cancer, 1994
• Selectivity ofmeso-tetra(hydroxyphenyl)porphyrins and chlorins and of photofrin II in causing photodamage in tumour, skin, muscle and bladder. The comcept of cost-benefit in analysing the results
  Lasers in Medical Science, 1993
• THE UPTAKE OF PORPHYRIN AND ZINC-METALLOPORPHYRIN BY THE PRIMATE PROSTATE
  Photochemistry and Photobiology, 1993
• Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma
  International Journal of Cancer, 1993
• PHOTOCHEMOTHERAPY OF CANCER: EXPERIMENTAL RESEARCH
  Photochemistry and Photobiology, 1992
• HOW DOES PHOTODYNAMIC THERAPY WORK?
  Photochemistry and Photobiology, 1992
• Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers
  Biochemical Journal, 1989